Compare Quantumscape Corp (QS) vs Tempus AI (TEM) Price & Performance

QuantumScape (QS) trades at $5.59, up 2.01% today but near its 52-week low, with a bearish technical signal from moving averages. The company reported a net loss of $435.05M for 2025, with negative ROE and ROA, and has no revenue as it develops solid-state batteries. Recent news highlights insider sales and delayed commercialization to 2029, while institutional interest includes new positions from Bank of New York Mellon (September 3, 2026).

Outlook remains high-risk due to pre-revenue status and execution delays, with analyst consensus cautious (72.7% hold, 27.3% sell). Opportunities hinge on battery technology success, but investors face substantial volatility and competitive threats from automakers. Cash flow trends show reliance on financing, with net cash flow turning positive in 2025 at $85.27M after prior losses.

Tempus AI (TEM) trades at $64.29, down 0.51% on the day, with a bullish technical signal and strong analyst support. The stock shows consistent earnings beats despite negative profitability, with a P/S of 7.99 and P/B of 26.23. Recent catalysts include FDA clearance for an AI ECG product and a $9.5 million ARPA-H award for autonomous AI in cardiology (Business Wire, September 9, 2026).

Outlook remains positive given analyst consensus and growth in precision medicine, but risks include sustained losses, high valuation multiples, and cash burn. The consensus price target is $69.11, implying potential upside, though investors must weigh the company's unprofitability against its innovation pipeline and market position.